Showing results (631-640 of 1,019) with videos related to
Sort By:
Pageof 102
Clinicoeconomics and Outcomes Research : CEOR|May 24, 2022
Incidence of Catastrophic Health Expenditures Amongst Hospitalized Neonates in Ekiti, Southwest NigeriaEzra O Ogundare, Adekunle B Taiwo, Oladele S Olatunya, et al.Clinicoeconomics and Outcomes Research : CEOR|June 24, 2022
Cost Utility of Bronchial Thermoplasty for Severe Asthma: Implications for Future Cost-Effectiveness Analyses Based on Phenotypic HeterogeneityJessica Keim-Malpass, H Charles MalpassClinicoeconomics and Outcomes Research : CEOR|June 3, 2021
Glycated Albumin for Glycemic Control in T2DM Population: A Multi-Dimensional EvaluationLucrezia Ferrario, Fabrizio Schettini, Angelo Avogaro, et al.Clinicoeconomics and Outcomes Research : CEOR|November 16, 2020
Treatment Sequencing Patterns in Patients with Metastatic Urothelial Cancer Treated in the Community Practice Setting in the United States: SPEAR-Bladder (Study informing treatment Pathway dEcision in bladder cAnceR)Gurjyot K Doshi, Abhijeet Bhanegaonkar, Mairead Kearney, et al.Clinicoeconomics and Outcomes Research : CEOR|February 6, 2020
Economic Outcomes Related to Persistence and Dosing of Celecoxib in Patients with Osteoarthritis (OA) Using a Retrospective Claims Database AnalysisCourtney Johnson, Jennifer Stephens, Christopher Walker, et al.Clinicoeconomics and Outcomes Research : CEOR|February 28, 2020
A Multicenter Retrospective Analysis on Clinical Effectiveness and Economic Assessment of Compound Reserpine and Hydrochlorothiazide Tablets (CRH) for HypertensionShunping Li, Xiaohan Liu, Lanting LiClinicoeconomics and Outcomes Research : CEOR|July 8, 2021
Real-World Six-Year National Cost-Minimization Analysis of IncobotulinumtoxinA and OnabotulinumtoxinA in the VA/DoD Healthcare SystemsRashid Kazerooni, Ileana M Howard, Adrienne M Keener, et al.Clinicoeconomics and Outcomes Research : CEOR|February 25, 2015
Health economics, equity, and efficiency: are we almost there?Marcos Bosi FerrazClinicoeconomics and Outcomes Research : CEOR|April 8, 2015
Disability-adjusted life years lost due to diabetes in France, Italy, Germany, Spain, and the United Kingdom: a burden of illness studyJosep Darbà, Lisette Kaskens, Bruno Detournay, et al.Clinicoeconomics and Outcomes Research : CEOR|May 4, 2023
Work Loss and Direct and Indirect Costs Associated with Parkinson's DiseaseMichelle Jerry, Steve Arcona, Donna McMorrow, et al.Pageof 102